NL7608496A - Werkwijze ter bereiding van farmacologisch actieve verbindingen alsmede farmaceutische preparaten die deze verbindingen bevatten. - Google Patents
Werkwijze ter bereiding van farmacologisch actieve verbindingen alsmede farmaceutische preparaten die deze verbindingen bevatten.Info
- Publication number
- NL7608496A NL7608496A NL7608496A NL7608496A NL7608496A NL 7608496 A NL7608496 A NL 7608496A NL 7608496 A NL7608496 A NL 7608496A NL 7608496 A NL7608496 A NL 7608496A NL 7608496 A NL7608496 A NL 7608496A
- Authority
- NL
- Netherlands
- Prior art keywords
- compounds
- preparation
- pharmaceutical preparations
- pharmacologically active
- preparations containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB31970/75A GB1564502A (en) | 1975-07-31 | 1975-07-31 | Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7608496A true NL7608496A (nl) | 1977-02-02 |
Family
ID=10331105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7608496A NL7608496A (nl) | 1975-07-31 | 1976-07-30 | Werkwijze ter bereiding van farmacologisch actieve verbindingen alsmede farmaceutische preparaten die deze verbindingen bevatten. |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US4083983A (xx) |
| JP (2) | JPS5219671A (xx) |
| AR (1) | AR213736A1 (xx) |
| AT (1) | AT356132B (xx) |
| AU (1) | AU502752B2 (xx) |
| BE (1) | BE844504A (xx) |
| BG (1) | BG27368A3 (xx) |
| CA (1) | CA1068711A (xx) |
| CH (1) | CH624938A5 (xx) |
| CS (1) | CS189018B2 (xx) |
| DD (1) | DD125204A5 (xx) |
| DE (1) | DE2634433A1 (xx) |
| DK (1) | DK316176A (xx) |
| ES (1) | ES450310A1 (xx) |
| FI (1) | FI762193A (xx) |
| FR (1) | FR2319343A1 (xx) |
| GB (1) | GB1564502A (xx) |
| GR (1) | GR60810B (xx) |
| HU (1) | HU173778B (xx) |
| IE (1) | IE43508B1 (xx) |
| IL (1) | IL50005A (xx) |
| LU (1) | LU75507A1 (xx) |
| NL (1) | NL7608496A (xx) |
| NO (1) | NO762661L (xx) |
| PH (1) | PH14555A (xx) |
| PL (1) | PL103684B1 (xx) |
| PT (1) | PT65348B (xx) |
| SE (1) | SE7608477L (xx) |
| SU (1) | SU692558A3 (xx) |
| ZA (1) | ZA764082B (xx) |
| ZM (1) | ZM9876A1 (xx) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4928863A (xx) * | 1972-07-13 | 1974-03-14 | ||
| JPS5078968U (xx) * | 1973-11-20 | 1975-07-08 | ||
| ZA774220B (en) * | 1976-07-28 | 1978-06-28 | Smith Kline French Lab | Pharmacologically active compounds |
| NZ186965A (en) | 1977-04-20 | 1980-02-21 | Ici Ltd | Guanidino derivatives and pharmaceutical compositions |
| US4165378A (en) | 1977-04-20 | 1979-08-21 | Ici Americas Inc. | Guanidine derivatives of imidazoles and thiazoles |
| US4233302A (en) * | 1977-12-23 | 1980-11-11 | Glaxo Group Limited | Amine derivatives and pharmaceutical compositions containing them |
| US4282363A (en) * | 1978-11-24 | 1981-08-04 | Bristol-Myers Company | 1-Nitro-2-(2-alkynylamino)-2-[(2-pyridylmethylthio)-ethylamino]ethylene derivatives |
| US4250316A (en) * | 1978-11-24 | 1981-02-10 | Bristol-Myers Company | Pyridyl guanidine anti-ulcer agents |
| NL8000869A (nl) * | 1979-02-16 | 1980-08-19 | Eisai Co Ltd | Cyanoguanidine-derivaten en werkwijze voor de bereiding daarvan. |
| PT74865B (en) * | 1981-05-27 | 1983-12-07 | Smithkline Beckman Corp | Process of preparing a 2-(pyridylbutylamino)-pyrimidone and of its pharmaceutically acceptable salts |
| SE8204879D0 (sv) * | 1982-08-26 | 1982-08-26 | Haessle Ab | Novel chemical intermediates |
| DE3232462A1 (de) * | 1982-09-01 | 1984-03-01 | Bayer Ag, 5090 Leverkusen | 2-nitro-1,1-ethendiamine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| JPH0828166B2 (ja) * | 1985-01-16 | 1996-03-21 | 松下電器産業株式会社 | サ−モスタツト |
| AU660132B2 (en) * | 1992-12-21 | 1995-06-08 | Bayer Aktiengesellschaft | Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridine |
| US5380734A (en) * | 1993-04-15 | 1995-01-10 | American Home Products Corporation | N-cyanoamidine derivatives as anti-influenza agents |
| EP3813900A4 (en) | 2018-06-29 | 2022-05-04 | 410 Medical, Inc. | SYSTEMS, DEVICE AND METHOD FOR FILTERING AIR FROM A FLUID LINE |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3968216A (en) * | 1969-10-29 | 1976-07-06 | Smith Kline & French Laboratories Limited | Method of inhibiting histamine activity with guanidine compounds |
| US3808336A (en) | 1970-06-25 | 1974-04-30 | Smithkline Corp | Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives |
| US3908014A (en) * | 1970-06-25 | 1975-09-23 | Smith Kline French Lab | Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives |
| US3905984A (en) * | 1971-03-09 | 1975-09-16 | Smith Kline French Lab | Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas |
| GB1338169A (en) * | 1971-03-09 | 1973-11-21 | Smith Kline French Lab | Ureas thioureas and guanidines |
| GB1397436A (en) * | 1972-09-05 | 1975-06-11 | Smith Kline French Lab | Heterocyclic n-cyanoguinidines |
| US4002759A (en) * | 1973-05-17 | 1977-01-11 | Smith Kline & French Laboratories Limited | Pyridylbutylamino ethylene compounds |
| GB1421792A (en) * | 1973-05-17 | 1976-01-21 | Smith Kline French Lab | Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them |
| US4025527A (en) * | 1973-07-13 | 1977-05-24 | Smith Kline & French Laboratories Limited | Certain thiazoles and oxazoles |
| GB1497260A (en) * | 1974-06-28 | 1978-01-05 | Smith Kline French Lab | Guanidine derivatives |
-
1975
- 1975-07-31 GB GB31970/75A patent/GB1564502A/en not_active Expired
-
1976
- 1976-07-09 PH PH18668A patent/PH14555A/en unknown
- 1976-07-09 ZA ZA764082A patent/ZA764082B/xx unknown
- 1976-07-09 PT PT65348A patent/PT65348B/pt unknown
- 1976-07-09 IL IL50005A patent/IL50005A/xx unknown
- 1976-07-13 US US05/704,877 patent/US4083983A/en not_active Expired - Lifetime
- 1976-07-13 DK DK316176A patent/DK316176A/da unknown
- 1976-07-21 CS CS764841A patent/CS189018B2/cs unknown
- 1976-07-22 CA CA257,590A patent/CA1068711A/en not_active Expired
- 1976-07-23 ZM ZM98/76A patent/ZM9876A1/xx unknown
- 1976-07-23 BE BE169228A patent/BE844504A/xx not_active IP Right Cessation
- 1976-07-27 AT AT552576A patent/AT356132B/de not_active IP Right Cessation
- 1976-07-27 SE SE7608477A patent/SE7608477L/xx not_active Application Discontinuation
- 1976-07-27 GR GR51358A patent/GR60810B/el unknown
- 1976-07-30 HU HU76SI1531A patent/HU173778B/hu unknown
- 1976-07-30 AU AU16453/76A patent/AU502752B2/en not_active Expired
- 1976-07-30 FI FI762193A patent/FI762193A/fi not_active Application Discontinuation
- 1976-07-30 CH CH978576A patent/CH624938A5/de not_active IP Right Cessation
- 1976-07-30 SU SU762386151A patent/SU692558A3/ru active
- 1976-07-30 FR FR7623453A patent/FR2319343A1/fr active Granted
- 1976-07-30 NL NL7608496A patent/NL7608496A/xx not_active Application Discontinuation
- 1976-07-30 JP JP51092245A patent/JPS5219671A/ja active Pending
- 1976-07-30 NO NO762661A patent/NO762661L/no unknown
- 1976-07-30 IE IE1708/76A patent/IE43508B1/en unknown
- 1976-07-30 PL PL1976191537A patent/PL103684B1/pl unknown
- 1976-07-30 LU LU75507A patent/LU75507A1/xx unknown
- 1976-07-30 AR AR264159A patent/AR213736A1/es active
- 1976-07-30 DD DD194159A patent/DD125204A5/xx unknown
- 1976-07-30 DE DE19762634433 patent/DE2634433A1/de not_active Withdrawn
- 1976-07-30 ES ES450310A patent/ES450310A1/es not_active Expired
- 1976-07-30 BG BG033887A patent/BG27368A3/xx unknown
-
1979
- 1979-02-21 US US06/013,579 patent/US4215126A/en not_active Expired - Lifetime
- 1979-11-15 US US06/094,412 patent/US4264608A/en not_active Expired - Lifetime
-
1980
- 1980-11-19 US US06/208,370 patent/US4426526A/en not_active Expired - Lifetime
-
1985
- 1985-02-25 JP JP60037341A patent/JPS60243069A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL7708741A (nl) | Werkwijze ter bereiding van prostaanzuurderiva- ten alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten. | |
| NL7614538A (nl) | Werkwijze ter bereiding van farmacologisch actieve heterocyclische verbindingen en farmaceutische preparaten die deze verbindingen bevatten. | |
| NL7510104A (nl) | Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat. | |
| NL7609414A (nl) | Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van 1-sulfonylbenzimidazoolderivaten. | |
| NL7608496A (nl) | Werkwijze ter bereiding van farmacologisch actieve verbindingen alsmede farmaceutische preparaten die deze verbindingen bevatten. | |
| NL7604583A (nl) | Werkwijze voor de bereiding van imidazool-deri- vaten en preparaten die ze bevatten. | |
| NL7706064A (nl) | Werkwijze ter bereiding van heterocyclische verbindingen alsmede van farmaceutische pre- paraten die deze verbindingen als actieve component omvatten. | |
| NL7606120A (nl) | Werkwijze voor de bereiding van farmacologisch werkzame heteroarylderivaten. | |
| NL7610480A (nl) | Werkwijze ter bereiding van hypolipemische ver- bindingen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
| NL7514255A (nl) | Werkwijze voor de bereiding van piperidylindolen en farmaceutische preparaten die ze bevatten. | |
| NL7513230A (nl) | Werkwijze voor de bereiding van farmaceutische tabletten. | |
| NL7612239A (nl) | Werkwijze ter bereiding van derivaten van dauno- rubicine alsmede preparaten die deze derivaten bevatten. | |
| NL7606178A (nl) | Werkwijze voor de bereiding van farmacologisch actieve heteroarylderivaten. | |
| NL7610057A (nl) | Werkwijze voor de bereiding van farmaceutische preparaten. | |
| NL7508706A (nl) | Werkwijze ter bereiding van pyrazofurinederivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten. | |
| NL7614233A (nl) | Werkwijze ter bereiding van farmaceutische pre- paraten en werkwijze ter bereiding van verschil- lende kristalvormen van natriumcefamandool. | |
| NL7714205A (nl) | Werkwijze ter bereiding van 5-fluoruracilderi- vaten en farmaceutische preparaten die deze derivaten bevatten. | |
| NL185841C (nl) | Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van voor toepassing daarbij geschikte 5-mercaptopyridoxinederivaten. | |
| NL7607693A (nl) | Werkwijze voor de bereiding van tegen ontste- kingen werkende en bloeddrukverlagende prepara- ten. | |
| NL164037C (nl) | Werkwijze ter bereiding van 1,4-dithiino- -2,3-cpyrrool-derivaten en van farmaceutische preparaten die deze derivaten bevatten. | |
| NL7608319A (nl) | Werkwijze ter bereiding van 1,2,3,4-tetrahydro- -isochinolinen, alsmede farmaceutische prepa- raten die deze verbindingen als actieve compo- nent bevatten. | |
| NL7610808A (nl) | Werkwijze ter bereiding van een farmaceutisch preparaat en werkwijze ter bereiding van anti- biotica. | |
| NL7709466A (nl) | Werkwijze ter bereiding van cefalosporinen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten. | |
| NL7612010A (nl) | Werkwijze ter bereiding van cefalosporineverbin- dingen en van farmaceutische mengsels die deze verbindingen bevatten. | |
| NL7611594A (nl) | Werkwijze ter bereiding van bicyclomycinederi- vaten alsmede farmaceutische preparaten die de- ze verbindingen als actieve component omvatten. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BV | The patent application has lapsed |